Hunan Jiudian Pharmaceutical Co Ltd (300705) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Based on the latest financial reports, Hunan Jiudian Pharmaceutical Co Ltd (300705) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥180.33 Million ≈ $26.39 Million USD) by net assets (CN¥2.66 Billion ≈ $388.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hunan Jiudian Pharmaceutical Co Ltd (300705) defensive interval to measure how many days the company can operate on defensive assets alone.

Hunan Jiudian Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Hunan Jiudian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Jiudian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Jiudian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
USIMINAS PFD ADR/10000 F:U1S0	0.016x
Van Phu - Invest Investment JSC VN:VPI	-0.004x
Qingdao Weflo Valve Co Ltd SHE:002871	0.050x
Ningbo Tech-Bank Co Ltd SHE:002124	0.116x
HDC Holdings Co Ltd KO:012630	-0.021x
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	0.000x
ZYLOX-TONBRDG.MED.TECH.H1 F:818	N/A
Shenzhen TXD Technology Co Ltd SHE:002845	-0.017x

Annual Cash Flow Conversion Efficiency for Hunan Jiudian Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Hunan Jiudian Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.53 Billion ≈ $369.74 Million	CN¥746.36 Million ≈ $109.22 Million	0.295x	+35.18%
2023-12-31	CN¥1.97 Billion ≈ $288.75 Million	CN¥431.19 Million ≈ $63.10 Million	0.219x	+26.13%
2022-12-31	CN¥1.55 Billion ≈ $227.20 Million	CN¥268.99 Million ≈ $39.36 Million	0.173x	-0.22%
2021-12-31	CN¥1.10 Billion ≈ $160.87 Million	CN¥190.87 Million ≈ $27.93 Million	0.174x	-3.27%
2020-12-31	CN¥835.68 Million ≈ $122.29 Million	CN¥149.99 Million ≈ $21.95 Million	0.179x	+50.70%
2019-12-31	CN¥761.87 Million ≈ $111.49 Million	CN¥90.74 Million ≈ $13.28 Million	0.119x	+25.36%
2018-12-31	CN¥718.16 Million ≈ $105.09 Million	CN¥68.23 Million ≈ $9.98 Million	0.095x	-21.99%
2017-12-31	CN¥660.26 Million ≈ $96.62 Million	CN¥80.42 Million ≈ $11.77 Million	0.122x	-28.61%
2016-12-31	CN¥323.43 Million ≈ $47.33 Million	CN¥55.18 Million ≈ $8.07 Million	0.171x	+34.88%
2015-12-31	CN¥254.51 Million ≈ $37.24 Million	CN¥32.20 Million ≈ $4.71 Million	0.126x	-11.82%
2014-12-31	CN¥209.87 Million ≈ $30.71 Million	CN¥30.11 Million ≈ $4.41 Million	0.143x	-17.81%
2013-12-31	CN¥175.85 Million ≈ $25.73 Million	CN¥30.69 Million ≈ $4.49 Million	0.175x	--

About Hunan Jiudian Pharmaceutical Co Ltd

SHE:300705 China Drug Manufacturers - Specialty & Generic

Market Cap

$753.20 Million

CN¥5.15 Billion CNY

Market Cap Rank

#10390 Global

#2864 in China

Share Price

CN¥10.29

Change (1 day)

-1.72%

52-Week Range

CN¥10.29 - CN¥19.87

All Time High

CN¥27.61